Why the study?
Does fixed-dose combination therapy (amlodipine/benazepril) improve blood pressure reduction compared to high-dose monotherapy in high-risk patients with Stage 2 hypertension?
Population
n=364 high-risk patients with Stage 2 hypertension
Comparison
Fixed-dose combination product as initial therapy vs High-dose monotherapy (amlodipine besylate)
Design
Review
Authors
Loading...
May support initial fixed-dose combination over high-dose monotherapy in Stage 2 hypertension; leaves open prospective randomized confirmation.
Does fixed-dose combination therapy (amlodipine/benazepril) improve blood pressure reduction compared to high-dose monotherapy in high-risk patients with Stage 2 hypertension?
Initial combination therapy for Stage 2 hypertension provides superior blood pressure reduction and potentially fewer adverse effects compared to high-dose monotherapy, supporting current guideline recommendations.
Thomas D. Giles (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: